Little or no change in body weight and fat mass was apparent in WT female mice on a high-fat diet treated with EPO (Supplementary Figure S1) due to the protective effect of estrogen against diet-induced obesity mediated via estrogen receptor α (Zhang et al., 2017; Lee et al., 2021). Here, EPO is linked to obesity disorder.